Axonics stock slips as market cap sits at USD 281.97 million
Published on 09/03/2026 at 07:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Axonics stock (US05465P1012) is valued at USD 281.97 million, and MarketBeat shows the shares at USD 10.34 on September 1, 2026, with a 52-week range of USD 9.95 to USD 10.45.
Latest quote and range
The same MarketBeat page lists volume at 36,015 shares and an average volume of 32,707 shares, putting the latest session volume 3,308 shares above that average. The stock also traded within a very tight band, with the quote sitting 3.01 percent below the 52-week high and 3.92 percent above the 52-week low.
Quarterly figures stay small
For fundamentals, MarketBeat says Axonics reported USD 0.03 EPS for the quarter, and that result sits in the latest reported earnings slot on the page. That makes the quarterly earnings print the only current operating figure in the source set, while the market cap and share price supply the other live data points.
For investors, the key number is the narrow USD 9.95 to USD 10.45 range. It shows a stock that has been moving in a compressed zone rather than breaking away from its recent trading corridor.
Axonics shares and the latest market snapshot
A compact view of the price range, market value, and the most recent quarterly EPS helps classify the stock on September 3, 2026.
Medical device focus
Axonics markets sacral neuromodulation systems for patients with bladder and bowel dysfunction, which keeps the company tied to a specialist medical device niche rather than a broad hospital portfolio. That product mix matters because the revenue base is shaped by a narrow therapy category, not by a wide consumer health business.
Trading level matters
On September 1, 2026, the shares closed at USD 10.34, and that price is very close to the 52-week high of USD 10.45. The distance from the high is just USD 0.11, which places the stock near the top of its recent range even after the modest session advance of USD 0.02.
Axonics stock data
- Company: Axonics, Inc.
- ISIN: US05465P1012
- Ticker: AXNX
- Trading venue: NASDAQ
- Price (as of September 1, 2026): USD 10.34
- Market capitalization: USD 281.97 million (as of September 2, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Index membership: None confirmed in the available source set
